Hyundai Bioscience Co., Ltd. (KOSDAQ: 048410)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,950
-300 (-2.11%)
Dec 19, 2024, 9:00 AM KST

Hyundai Bioscience Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-10,440-14,499-15,807-20,051-8,2601,121
Upgrade
Depreciation & Amortization
672.571,4351,7822,7033,7783,813
Upgrade
Loss (Gain) From Sale of Assets
-----3.5
Upgrade
Asset Writedown & Restructuring Costs
4,7694,769-7,5172,829-
Upgrade
Loss (Gain) From Sale of Investments
-123.67-123.67-910.99---
Upgrade
Loss (Gain) on Equity Investments
4,745--8,834-93.91-1,542166.12
Upgrade
Stock-Based Compensation
19.91402.42596.94578.261,032753.05
Upgrade
Provision & Write-off of Bad Debts
134.72-28.785,260-583.99-212.84206.52
Upgrade
Other Operating Activities
1,837911.44-79.493,9252,1701,874
Upgrade
Change in Accounts Receivable
1,610864.231,1843,5264,5852,123
Upgrade
Change in Inventory
1,854358.12403.6864.91,865-2,209
Upgrade
Change in Accounts Payable
-245.17-256.2503.5713.431,3551,445
Upgrade
Change in Other Net Operating Assets
227.49159.77-642.061,063-97.7-117.65
Upgrade
Operating Cash Flow
5,060-6,008-16,544-538.487,5029,179
Upgrade
Operating Cash Flow Growth
-----18.27%83.38%
Upgrade
Capital Expenditures
-84.95-539.7-1,544-3,747-25,204-3,065
Upgrade
Sale (Purchase) of Intangibles
-2,000-47.84--15.12--10,000
Upgrade
Investment in Securities
-16,9346,00010,210-13,010941.66-2,927
Upgrade
Other Investing Activities
-1,009-557-0.41,7732.43-113.45
Upgrade
Investing Cash Flow
-19,8345,1778,518-12,359-26,831-14,697
Upgrade
Short-Term Debt Issued
----2,000-
Upgrade
Long-Term Debt Issued
----33,0007,000
Upgrade
Total Debt Issued
20,001---35,0007,000
Upgrade
Short-Term Debt Repaid
--500-500---
Upgrade
Long-Term Debt Repaid
--362.88-1,194-1,246-1,182-948.42
Upgrade
Total Debt Repaid
-455.09-862.88-1,694-1,246-1,182-948.42
Upgrade
Net Debt Issued (Repaid)
19,546-862.88-1,694-1,24633,8186,052
Upgrade
Issuance of Common Stock
158.691,0943,5964,449-2,110
Upgrade
Other Financing Activities
-380.94-289.18-229.04-209.66-867.11-281.4
Upgrade
Financing Cash Flow
19,324-57.971,6732,99432,9517,880
Upgrade
Foreign Exchange Rate Adjustments
104.6-31.72-103.42-122.2937.9530.74
Upgrade
Miscellaneous Cash Flow Adjustments
-0----0-
Upgrade
Net Cash Flow
4,655-920.54-6,456-10,02613,6602,393
Upgrade
Free Cash Flow
4,975-6,548-18,087-4,285-17,7026,113
Upgrade
Free Cash Flow Margin
31.45%-69.06%-230.36%-46.37%-141.49%20.32%
Upgrade
Free Cash Flow Per Share
124.96-164.62-459.44-116.08-492.91176.47
Upgrade
Cash Interest Paid
380.94289.18222.4209.66259.11281.4
Upgrade
Cash Income Tax Paid
-19.19-17.9978.92-15.6411.89
Upgrade
Levered Free Cash Flow
1,608-4,900-8,3881,337-21,504-3,576
Upgrade
Unlevered Free Cash Flow
2,474-4,704-8,1083,214-20,797-3,092
Upgrade
Change in Net Working Capital
-3,939-576.35-8,098-10,079-3,398-4,647
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.